BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 16434728)

  • 1. Innate immune signaling and Porphyromonas gingivalis-accelerated atherosclerosis.
    Gibson FC; Yumoto H; Takahashi Y; Chou HH; Genco CA
    J Dent Res; 2006 Feb; 85(2):106-21. PubMed ID: 16434728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyromonas gingivalis mediated periodontal disease and atherosclerosis: disparate diseases with commonalities in pathogenesis through TLRs.
    Gibson FC; Genco CA
    Curr Pharm Des; 2007; 13(36):3665-75. PubMed ID: 18220804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal innate immune mechanisms relevant to atherosclerosis.
    Amar S; Engelke M
    Mol Oral Microbiol; 2015 Jun; 30(3):171-85. PubMed ID: 25388989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role for Porphyromonas gingivalis in the progression of atherosclerosis.
    Wang Q; Zhou X; Huang D
    Med Hypotheses; 2009 Jan; 72(1):71-3. PubMed ID: 18829178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal immunization with Porphyromonas gingivalis and atherosclerosis.
    Koizumi Y; Kurita-Ochiai T; Oguchi S; Yamamoto M
    Immunopharmacol Immunotoxicol; 2009; 31(3):352-7. PubMed ID: 19555215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis.
    Gibson FC; Ukai T; Genco CA
    Front Biosci; 2008 Jan; 13():2041-59. PubMed ID: 17981690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate immune recognition of invasive bacteria accelerates atherosclerosis in apolipoprotein E-deficient mice.
    Gibson FC; Hong C; Chou HH; Yumoto H; Chen J; Lien E; Wong J; Genco CA
    Circulation; 2004 Jun; 109(22):2801-6. PubMed ID: 15123526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: Pathogen-induced inflammation at sites distant from oral infection: bacterial persistence and induction of cell-specific innate immune inflammatory pathways.
    Hayashi C; Gudino CV; Gibson FC; Genco CA
    Mol Oral Microbiol; 2010 Oct; 25(5):305-16. PubMed ID: 20883220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of oral pathogens with toll-like receptors: possible role in atherosclerosis.
    Hajishengallis G; Sharma A; Russell MW; Genco RJ
    Ann Periodontol; 2002 Dec; 7(1):72-8. PubMed ID: 16013219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated atherosclerosis.
    Yamaguchi Y; Kurita-Ochiai T; Kobayashi R; Suzuki T; Ando T
    Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25663345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periodontal innate immune mechanisms relevant to obesity.
    Amar S; Leeman S
    Mol Oral Microbiol; 2013 Oct; 28(5):331-41. PubMed ID: 23911141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. E-selectin expression induced by Porphyromonas gingivalis in human endothelial cells via nucleotide-binding oligomerization domain-like receptors and Toll-like receptors.
    Wan M; Liu JR; Wu D; Chi XP; Ouyang XY
    Mol Oral Microbiol; 2015 Oct; 30(5):399-410. PubMed ID: 25939768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating periodontal risk for patients at risk of or suffering from atherosclerosis: recent biological hypotheses and therapeutic consequences.
    Huck O; Saadi-Thiers K; Tenenbaum H; Davideau JL; Romagna C; Laurent Y; Cottin Y; Roul JG
    Arch Cardiovasc Dis; 2011 May; 104(5):352-8. PubMed ID: 21693372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL.
    Kurita-Ochiai T; Yamamoto M
    Biomed Res Int; 2014; 2014():595981. PubMed ID: 24949459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dimensional and three-dimensional models for studying atherosclerosis pathogenesis induced by periodontopathogenic microorganisms.
    Gualtero DF; Lafaurie GI; Fontanilla MR
    Mol Oral Microbiol; 2018 Feb; 33(1):29-37. PubMed ID: 28984079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen-mediated inflammatory atherosclerosis is mediated in part via Toll-like receptor 2-induced inflammatory responses.
    Hayashi C; Madrigal AG; Liu X; Ukai T; Goswami S; Gudino CV; Gibson FC; Genco CA
    J Innate Immun; 2010; 2(4):334-43. PubMed ID: 20505314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.
    Pan S; Lei L; Chen S; Li H; Yan F
    Int Immunopharmacol; 2014 Dec; 23(2):701-8. PubMed ID: 25445963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Innate Immune Responses of Human Endothelial Cells Induced by
    Ho MH; Guo ZM; Chunga J; Goodwin JS; Xie H
    Front Cell Infect Microbiol; 2016; 6():139. PubMed ID: 27826542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Periodontal pathogens invade gingiva and aortic adventitia and elicit inflammasome activation in αvβ6 integrin-deficient mice.
    Velsko IM; Chukkapalli SS; Rivera-Kweh MF; Zheng D; Aukhil I; Lucas AR; Larjava H; Kesavalu L
    Infect Immun; 2015 Dec; 83(12):4582-93. PubMed ID: 26371120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogen-accelerated atherosclerosis occurs early after exposure and can be prevented via immunization.
    Miyamoto T; Yumoto H; Takahashi Y; Davey M; Gibson FC; Genco CA
    Infect Immun; 2006 Feb; 74(2):1376-80. PubMed ID: 16428788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.